Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Invested Capital (2019 - 2025)

AVITA Medical filings provide 7 years of Invested Capital readings, the most recent being $26.3 million for Q4 2025.

  • On a quarterly basis, Invested Capital rose 485.33% to $26.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $26.3 million, a 485.33% increase, with the full-year FY2025 number at $26.3 million, up 485.33% from a year prior.
  • Invested Capital hit $26.3 million in Q4 2025 for AVITA Medical, down from $35.8 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $118.9 million in Q1 2021 to a low of -$9.9 million in Q2 2025.
  • Median Invested Capital over the past 5 years was $65.8 million (2023), compared with a mean of $59.8 million.
  • The widest YoY moves for Invested Capital: up 485.33% in 2025, down 141.36% in 2025.
  • AVITA Medical's Invested Capital stood at $104.6 million in 2021, then decreased by 19.01% to $84.7 million in 2022, then tumbled by 42.11% to $49.1 million in 2023, then plummeted by 90.83% to $4.5 million in 2024, then soared by 485.33% to $26.3 million in 2025.
  • The last three reported values for Invested Capital were $26.3 million (Q4 2025), $35.8 million (Q3 2025), and -$9.9 million (Q2 2025) per Business Quant data.